Aerie Pharma Eyes $58M IPO For Glaucoma Drug Push | Ben Fidler | 09/18/13 | New York |
Biotech VCs, Stung by Startup Returns, Elbow into Royalty Financing | Steve Dickman | 08/16/13 | Boston |
Ophthotech Eyes $85M IPO With Late-Stage Clinical Trial in Sight | Ben Fidler | 08/15/13 | New York |
FDA Clears New Version of Tyrx’s Infection-Fighting Pacemaker Sleeve | Ben Fidler | 07/09/13 | New York |
East Coast Life Sciences Roundup: Epizyme, Alkermes, Ophthotech, & More | Ben Fidler | 05/31/13 | Boston |
Ophthotech Nabs $175M To Fund Late-Stage Trial For Eye Drug | Ben Fidler | 05/29/13 | New York |
NanoString Technologies Maneuvers In Line for $86M IPO | Luke Timmerman | 05/20/13 | Seattle |
NanoString Technologies Garners $15,300,000 Series E Financing Round | VentureDeal | 12/03/12 | Seattle |
Pearl Therapeutics Secures $65,000,000 Series D Round | VentureDeal | 11/13/12 | San Francisco |
Cardiac Dimensions Nabs $5.8M for Heart Failure Device | Luke Timmerman | 09/12/12 | Seattle |
NanoString Makes IPO Prep Move, Adds Finance Vet to Board | Luke Timmerman | 07/18/12 | Seattle |
Sientra Secures $65,000,000 Series C Round | VentureDeal | 03/29/12 | San Diego |
Shire Shells Out $100M to Buy Ferrokin Biosciences | Luke Timmerman | 03/15/12 | San Francisco |
Clarus Ventures Adjusts to Unpredictable Biotech World | Luke Timmerman | 01/20/12 | Boston |
San Diego Life Sciences Roundup: Isis, Elevation, Proacta, and More | Bruce V. Bigelow | 01/06/12 | San Diego |
Catabasis Pharmaceuticals Garners $8,000,000 Series A Round | VentureDeal | 12/13/11 | Boston |
Momenta Gets a Steal on Promising Scientific Asset from Once-Hot Virdante | Arlene Weintraub | 12/07/11 | Boston |
Best Buy Picks Up MindShift, Termeer Funds NanoString, Basho Adds $5M More, & More Boston-Area Deals News | Erin Kutz | 11/09/11 | Boston |
NanoString Grabs $20M From GE, Former Genzyme CEO to Pursue Molecular Diagnostics | Luke Timmerman | 11/07/11 | Seattle |
NanoString Technologies Obtains $20,000,000 Series D Funding | VentureDeal | 11/07/11 | Seattle |
Catabasis Begins Human Trials of Omega-3-Inspired Diabetes Treatment | Arlene Weintraub | 10/20/11 | Boston |
Cleave Biosciences Nabs $42M, Veteran Execs, to Chase Personalized Cancer Therapies | Luke Timmerman | 10/11/11 | San Francisco |
Cleave Biosciences Receives $42,000,000 Series A Financing Round | VentureDeal | 10/11/11 | San Francisco |
$41M for Restoration Robotics’ Hair Transplant Robot | Wade Roush | 08/04/11 | San Francisco |
Restoration Robotics Lands $41,000,000 Series C Financing | VentureDeal | 08/03/11 | San Francisco |
SARCode Secures $44,000,000 Series B Round | VentureDeal | 07/18/11 | San Francisco |
Allozyne Acquires Poniard Pharmaceuticals, Finds Backdoor Route to NASDAQ | Luke Timmerman | 06/22/11 | Seattle |
VBI Progressing with Vaccines That Don’t Require Refrigeration | Ryan McBride | 03/24/11 | Boston |
Alexion Pharma Gobbles Up Taligen in $111M Buyout | Ryan McBride | 01/31/11 | Boston |
Pearl Therapeutics, Fresh Off Big VC Round, Tops $3B Lung Drug in Head-to-Head Trial | Luke Timmerman | 12/01/10 | San Francisco |